Answers are grounded in this paper and cite their sources.
Our results suggest that the new flash CGM system can offer cost savings compared to blood glucose monitoring in Medicaid beneficiaries treated with IIT, especially T1D adults, and children and adolescents. These findings support expanding access to CGM by Medicaid plans.
No takes yet. Share an insight, caveat, or question.
Frank et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: